Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
ID: 349810Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $450K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349810

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-23-249.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research," which requires clinical trials under the R34 mechanism. This initiative aims to advance research on alcohol use disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing treatment appeal, examining cost structures, studying dissemination of evidence-based approaches, and reducing health disparities among affected populations. The funding, capped at $450,000 for projects lasting up to three years, is open to a diverse range of eligible applicants, including educational institutions and community organizations. Interested parties should note that the application submission window opened on September 16, 2023, with a closing date of September 7, 2026, and can direct inquiries to grantsinfo@nih.gov for further information.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-23-249-Full-Announcement.html
    PAR-23-249.html
    The National Institute on Alcohol Abuse and Alcoholism (NIAAA), under the Department of Health and Human Services, has released a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research" which requires clinical trials (R34 planning grant). The purpose is to advance research on various aspects of alcohol use disorder (AUD), including medications, behavioral therapies, recovery processes, and innovative technologies. This NOFO highlights the urgent need for effective AUD treatment methods due to public health concerns, economic costs, and the necessity of tailored interventions for special populations. Key dates for submissions include an opening date of September 16, 2023, with subsequent deadlines through 2026. Eligible applicants encompass various organizations, including educational institutions and nonprofits, with projects capped at three years and a budget limit of $450,000. The review process will evaluate significance, investigator qualifications, innovation, and the appropriateness of methods. Overall, this funding initiative aims to foster significant breakthroughs in AUD treatment through a structured research approach, addressing pressing public health challenges and supporting diverse populations affected by alcohol use disorders.
    Similar Opportunities
    Alcohol Health Services Research (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Alcohol Abuse and Alcoholism (NIAAA), has announced a funding opportunity titled "Alcohol Health Services Research (R34 Clinical Trial Optional)" (PAR-23-252). This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on improving access to treatment, reducing stigma, examining cost structures, and implementing evidence-based approaches, particularly for health disparity populations. The total project budget is capped at $450,000 over a three-year period, and eligible applicants include higher education institutions, nonprofits, and government agencies, with a specific emphasis on those serving underrepresented communities. Interested parties should submit their applications electronically by October 16, 2023, with funding available until September 8, 2026. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)" aimed at advancing research in the treatment and recovery from alcohol use disorder (AUD). This grant supports clinical trials focusing on various aspects of AUD, including medication development, behavioral therapies, and innovative treatment technologies, particularly for populations facing health disparities. The funding is crucial for enhancing the understanding and efficacy of AUD treatments, ultimately contributing to improved public health outcomes. Eligible applicants can receive up to $500,000 in direct costs over a maximum project period of five years, with key submission deadlines on October 5, 2023, and February 5, 2024. For more information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-23-250.html.
    Alcohol Health Services Research (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the National Institute on Alcohol Abuse and Alcoholism (NIAAA) for the Alcohol Health Services Research (R01 Clinical Trial Optional) grant. This initiative aims to address the treatment gap for individuals with Alcohol Use Disorder (AUD) by focusing on five key areas: increasing access to treatment, enhancing the appeal of treatment, examining cost structures and insurance systems, studying the dissemination and implementation of evidence-based approaches, and reducing health disparities among affected populations. The grant allows for a maximum budget of $500,000 and a project period of up to five years, with applications due by September 7, 2026. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 - Clinical Trial Optional)." This initiative aims to support pilot and preliminary research that prepares for larger-scale trials focused on improving access to and the effectiveness of treatment services for substance use disorders. The funding is intended to facilitate the testing of various intervention approaches and methodologies, ultimately contributing to the development of effective treatment strategies that address health disparities among vulnerable populations. Applicants may receive up to $450,000 over a three-year period, with proposals due by 5:00 PM local time on January 7, 2025. For further information, interested parties can contact the NIH OER Webmaster at grantsinfo@nih.gov or visit the official announcement at http://grants.nih.gov/grants/guide/pa-files/PA-21-180.html.
    Investigational New Drug (IND)-enabling and Early-Stage Development of Medications to Treat Alcohol Use disorder and Alcohol-Associated Organ Damage (U43/U44 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) aimed at supporting the development of medications for Alcohol Use Disorder (AUD) and Alcohol-Associated Organ Damage (AAOD) through Small Business Innovation Research (SBIR) applications. Eligible applicants, specifically U.S.-based small businesses, are required to propose therapeutic agents that have a solid foundation of background data, ready for transition to preclinical and clinical development, with a focus on advancing these candidates towards FDA approval. This initiative is critical given the limited FDA-approved treatments available for AUD and AAOD, and it emphasizes the importance of rigorous scientific and regulatory standards in drug development. Funding amounts include up to $1 million for Phase I and $1.5 million for Phase II, with project durations of up to two years and three years, respectively. Interested parties can find more information and contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, with the application deadline set for December 4, 2024.
    Specialized Alcohol Research Centers (P50 Clinical trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of Specialized Alcohol Research Centers (P50), aimed at advancing interdisciplinary research on Alcohol Use Disorder (AUD) and related issues. This initiative seeks to foster collaborative research that examines the etiology, treatment, and prevention of AUD, particularly focusing on health disparities among various racial and ethnic populations. The total funding commitment for this opportunity is up to $7 million, with applications due by November 15, 2024, and a requirement for a Plan for Enhancing Diverse Perspectives (PEDP) to be included in submissions. Interested applicants can find more information and submit their proposals electronically through Grants.gov, with inquiries directed to grantsinfo@nih.gov.
    HIV Prevention and Alcohol (R34 Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "HIV Prevention and Alcohol (R34 Clinical Trials Optional)" aimed at expanding the HIV/AIDS prevention toolkit among populations impacted by alcohol use. This grant seeks to support research that integrates effective prevention and treatment interventions while addressing the behavioral and biological risks associated with alcohol consumption, particularly among high-risk groups. The initiative is crucial for informing the design of future clinical trials focused on HIV prevention, with an anticipated funding amount of approximately $1.5 million for 2-4 awards. Interested applicants, including higher education institutions and community organizations, must submit their proposals by September 7, 2025, and can find additional information at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled the Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional) aimed at promoting research for innovative behavioral and integrative treatments for drug and alcohol use disorders. This initiative encourages the development and testing of interventions across various stages, from initial generation and refinement to efficacy testing in controlled and real-world settings, focusing on enhancing treatment efficacy and accessibility, particularly in community environments. Applications are welcomed from a diverse range of organizations, including higher education institutions and for-profit entities, with no budget limit specified, and must be submitted by March 21, 2025. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-22-182.html.
    Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Behavioral and Integrative Treatment Development Program (R34 Clinical Trial Optional), a federal grant opportunity aimed at funding research for developing and testing behavioral treatments for substance use and dependence. This initiative seeks to encourage research that tests the efficacy of behavioral interventions, examines mechanisms of behavior change, and optimizes treatment approaches, particularly for individuals with comorbidities and those in drug abuse treatment. The program is crucial for advancing substance abuse treatment and addressing health disparities, with a maximum funding amount of $450,000 available over three years. Interested applicants, including various educational institutions and community organizations, must submit their proposals by March 21, 2025, and can find additional information at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for inquiries.
    Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Alcohol Research-Related Resource Award (R24 Clinical Trial Not Allowed), aimed at supporting investigator-initiated resources that enhance biomedical, behavioral, and social sciences research related to alcohol. This grant mechanism focuses on providing essential data, materials, and services to the broader alcohol research community, rather than supporting hypothesis-driven research, which should be submitted through other mechanisms. The NIH seeks to create high-quality resources that do not duplicate existing offerings, emphasizing the importance of diversity in research participation and encouraging applications from organizations serving underrepresented groups. Applications are due by January 25, 2024, and the project periods can last up to five years, with no cost-sharing or matching requirements. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.